Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Amgen Inc.
3209
Amgen Inc.
Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
Suggest edits
Founded
1985
Raised
$12M
Follow us
Featured on
Companies in the same industry
Bamboo Therapeutics
Immatics
Cryofocus Biotech
BioAtla, LLC
Care Point Software
Biomoti
TapImmune
ViewPoint Therapeutics
IRX Therapeutics, Inc.
Biofourmis
Alexa global traffic share
Twitter followers
Overview
News
Investments
36
Portfolio
Portfolio Tracker
Acquisitions
4
Apps
1
Add info
Latest investments
Show all
$42,000,000
Venture capital (Series A)
QurAlis
$25,500,000
Venture capital
GPB Scientific
Team Size
10000+
Employees
I work here
Location
United States
Headquarters
Explore United States
Geographical Focus
United States
Markets focus
Biotechnology
Past year's investments
Amgen Ventures participated in fewer than 3 rounds over the past year
Latest rounds
QurAlis: Venture capital (Series A) ($42M)
GPB Scientific: Venture capital ($25.5M)
EnClear Therapies: Venture capital (Series A) ($10M)
Main Co-investors
Skyline Ventures
United States
GV
United States
Alta Partners
United States
